GeneBe

rs80357970

Variant names:
GermlineCancer (beta)

Variant summary

Our verdict is Pathogenic.
+11 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
 The variant received 11 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_ModerateO2_Very_StrongO3_Supporting

The NM_007294.4(BRCA1):c.2475delC (p.Asp825GlufsTer21) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene BRCA1 is a tumor suppressor gene (CancerMine: 412 TSG, 22 oncogene, 49 driver citations). The gene BRCA1 is a cancer driver gene (CancerMine: 412 TSG, 22 oncogene, 49 driver citations). The variant allele was found at a cumulative frequency of 0.0000112 (AC=18) in the gnomAD database across 1,613,794 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000852. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). The variant has been observed in cBioPortal in 3 samples across 3 studies and 2 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

BRCA1
NM_007294.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic reviewed by expert panel P:35O:1

Conservation

PhyloP100: 0.394

Publications

47 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007294.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 11 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★★)
O2Null variant in tumour suppressor gene
Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 412 citations, oncogene: 22 citations, driver: 49 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 0.
O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000009 — very rare (O3 supporting [+1])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRCA1 NM_007294.4
MANE Select
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 23
frameshift
Prot: NP_009225.1UniProt: P38398-1
BRCA1 NM_001407581.1
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 24
frameshift
Prot: NP_001394510.1UniProt: A0A2R8Y7V5
BRCA1 NM_001407582.1
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 24
frameshift
Prot: NP_001394511.1UniProt: A0A2R8Y7V5

Ensembl Transcripts

BRCA1 ENST00000357654.9
TSL:1MANE Select
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 23
frameshift
Prot: ENSP00000350283.3UniProt: P38398-1
BRCA1 ENST00000471181.7
TSL:1
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 24
frameshift
Prot: ENSP00000418960.2UniProt: P38398-7
BRCA1 ENST00000470026.6
TSL:1
HGVSc / HGVSpc.2475delCp.Asp825GlufsTer21
Exon rankExon 10 of 23
frameshift
Prot: ENSP00000419274.2UniProt: P38398-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000131
AC:2
Hom:0
AN:152216
Cov:32
GnomAD2 exomes
AF: 0.00000399
AC:1
AN:250912
GnomAD4 exome
AF: 0.0000109
AC:16
Hom:0
AN:1461578
Cov:41
GnomAD4 genome
AF: 0.0000131
AC:2
Hom:0
AN:152216
Cov:32
TOPMed (Bravo)
AF: 0.00000378
AC:1
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:13470
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
 0.0000352 128420 0.0000347 128844
Epi25
(Epilepsy)
 0.00 041958 0.0000150 166888
SCHEMA
(Schizophrenia)
 0.0000155 164544 0.0000317 4126284
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
14
-
-
Breast-ovarian cancer, familial, susceptibility to, 1 (14)
9
-
-
not provided (9)
5
-
-
Hereditary breast ovarian cancer syndrome (6)
2
-
-
Hereditary cancer-predisposing syndrome (2)
1
-
-
BRCA1-related cancer predisposition (1)
1
-
-
BRCA1-related disorder (1)
1
-
-
Familial cancer of breast;C2676676:Breast-ovarian cancer, familial, susceptibility to, 1;C3280442:Pancreatic cancer, susceptibility to, 4;C4554406:Fanconi anemia, complementation group S (1)
1
-
-
Familial cancer of breast;C2676676:Breast-ovarian cancer, familial, susceptibility to, 1;C4554406:Fanconi anemia, complementation group S (1)
1
-
-
Ovarian neoplasm (1)

Computational Scores

Mutation Taster
N/A0/200disease causing (ClinVar)
PhyloP100
Benign0.39
Showing 2 of 2 scores

Splicing Scores

SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs80357970;
hg19: chr17-41245072;
Feedback | API | Annotate VCF | Sitemap | About | Privacy & Terms
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.